Navigation Links
Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
Date:5/15/2012

d a variable risk of transformation to acute myeloid leukemia.  It is estimated that MDS affects approximately 300,000 people worldwide.  According to the American Cancer Society, 10,000–20,000 new cases of MDS are diagnosed each year in the United States, with survival rates ranging from six months to six years.  MDS patients often require multiple blood transfusions to manage their disease.

Telintra has a novel mechanism of action that inhibits an enzyme called glutathione S-transferase P1-1, which leads to activation of Jun kinase, a key regulator of cellular growth and differentiation of blood precursor cells; this mechanism induces cancer cell death, or apoptosis, in human leukemia cell lines. Telintra is also being evaluated in a Phase 2 clinical trial in Revlimid refractory and resistant deletion 5q MDS patients and a Phase 2b clinical trial in non-deletion 5q MDS patients.  Additional information about Telintra is available at www.telik.com.

About Telik, Inc.

Telik, Inc. of Palo Alto, CA, is a clinical-stage drug development company focused on discovering and developing small-molecule drugs to treat cancer.  The company's most advanced drug candidate is Telintra, a modified glutathione analog intended for the treatment of hematologic disorders including myelodysplastic syndrome, followed by Telcyta®, a cancer-activated prodrug for the treatment of a variety of cancers.  Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small-molecule drug candidates.

This press release contains "forward-looking" statements regarding the future development of Telintra, the safety and effectiveness of Telintra in treating MDS, whether Telintra treatment results in hematologic improvement in patients with MDS, whether Telintra reduces the need for, or offer
'/>"/>

SOURCE Telik, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Telik Regains Compliance With Minimum Bid Price Requirement
2. Telik Announces Fourth Quarter and 2011 Year End Financial Results and 2012 Financial Guidance
3. Telik Announces Presentation and Webcast at 14th Annual BIO CEO & Investor Conference
4. Telik Announces Telintra Clinical Presentations at the Annual Meeting of the American Society of Hematology
5. Telik Announces Third Quarter 2011 Financial Results
6. Telik Announces Publication of a Report of Complete Response of G-CSF Resistent Severe Idiopathic Chronic Neutropenia Following Treatment with Telintra®
7. Telik Announces Ezatiostat (Telintra®) Preclinical Presentation at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Telik Announces Initiation of a Phase 2b Clinical Trial of Telintra® (Ezatiostat HCL) in Patients With Low to Intermediate-1 Risk Non-Deletion (5q) Myelodysplastic Syndrome
9. Telik Announces Publication in the Journal Cancer of a Phase 2 Randomized Multicenter Study of Two Extended Dosing Schedules of Oral Ezatiostat in Low to Intermediate-1 Risk Myelodysplastic Syndrome
10. Telik Announces First Quarter 2011 Financial Results
11. Telik Announces Presentation of New Data on the Characterization of Novel Ezatiostat (TELINTRA®, TLK199) Analogs at American Association for Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... , Nov. 28, 2014 The market for ... reach 7.9 billion dollars in 2014 according to Kalorama ... existing equipment and growing incidence of disease are driving ... X-Ray and Digital X-Ray: World Market Analysis ... X-Ray: World Market Analysis can be obtained at: ...
(Date:11/28/2014)... 2014 Aratana Therapeutics, Inc. (NASDAQ: PETX ... or acquisition, development and commercialization of innovative biopharmaceutical products ... that it will present at the 26 th ... 2-3, 2014, at the New York Palace Hotel in ... Steven St. Peter , M.D., President and Chief Executive ...
(Date:11/28/2014)... , Nov. 28, 2014  (Booth #7309, North ... release of its newest product, DCMSYS Interface WebBridge, at ... December 5th at McCormick Place, Chicago, Illinois ... Designed for medical facilities of ... party application to upload any non-standard data (e.g. JPEG, ...
Breaking Medicine Technology:Kalorama: X-Ray and Digital X-Ray Market Nears 8 Billion This Year 2Kalorama: X-Ray and Digital X-Ray Market Nears 8 Billion This Year 3Aratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Dicom Systems Announces WebBridge Interface at RSNA 2014 2
... (Nasdaq: OMCL ), a leading provider of system ... quarter and year ended December 31, 2010. ... was $57.3 million, up $1.0 million or 1.7% from the ... from the fourth quarter of 2009.  Revenue for the year ...
... Thoratec Corporation (Nasdaq: THOR ), a world ... support and restore failing hearts, said today that revenues ... over those in fiscal 2009. Results from ... quarter of fiscal 2010 and 2009 exclude contributions from ...
Cached Medicine Technology:Omnicell Announces Fourth Quarter and Full Year 2010 Results 2Omnicell Announces Fourth Quarter and Full Year 2010 Results 3Omnicell Announces Fourth Quarter and Full Year 2010 Results 4Omnicell Announces Fourth Quarter and Full Year 2010 Results 5Omnicell Announces Fourth Quarter and Full Year 2010 Results 6Omnicell Announces Fourth Quarter and Full Year 2010 Results 7Omnicell Announces Fourth Quarter and Full Year 2010 Results 8Omnicell Announces Fourth Quarter and Full Year 2010 Results 9Omnicell Announces Fourth Quarter and Full Year 2010 Results 10Omnicell Announces Fourth Quarter and Full Year 2010 Results 11Omnicell Announces Fourth Quarter and Full Year 2010 Results 12Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 2Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 3Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 4Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 5Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 6Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 7Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 8Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 9Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 10Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 11Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 12Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 13Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 14Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 15
(Date:11/28/2014)... Brosix is always making changes to its infrastructure architecture ... efficient, effective, and secure experience. Most recently, the company ... ability to setup local servers for each country or ... around the globe. , 2. The ability to setup ... require millions of users in one network. , 3. ...
(Date:11/28/2014)... New York, NY (PRWEB) November 28, 2014 ... Auto Salvage ( http://www.rustysautosalvage.com ), one of the nation's ... used, junk and salvage vehicles to be more competitive ... their customer’s lives during this festive time of year. ... friends, many car owners across the US also deal ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Junk-A-Car ( ... is expanding their service offerings to help drivers, especially ... Philadelphia and Washington, D.C. metropolitan areas deal with the ... across a large part of the country. , With ... resulting in hundreds of totaled, crashed and junk ...
(Date:11/28/2014)... 2014 Dr. Diane Walder, one of ... the addition of Dr. Bridgit Nolan to her practice ... after having completed her dermatology residency at the University ... invited Dr. Nolan to join her practice ... cosmetic dermatology. Not only does Dr. Nolan strive to ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Novatus, ... announced its Release v5.1 which provides customers with ... workflow options. , “As we continue to ... to provide more functionality and improved performance in ... Gambotz, CEO for Novatus. “With the enhancements that ...
Breaking Medicine News(10 mins):Health News:Brosix Infrastructure Architecture Changes to Benefit Users 2Health News:Rusty's Auto Salvage Increasing Their Cash Offers to Help Drivers Save Throughout the Busy Holiday Season 2Health News:Junk-A-Car Expanding Service to Assist U.S. Car Owners That May be Affected by Severe Winter Storms 2Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Novatus Releases v5.1 with New Advanced Reporting Capabilities 2
... Following its recent,merger with Echo Therapeutics, Inc., ... platform-enabled transdermal specialty,therapeutics and diagnostics company, today announced ... Therapeutics, Inc., effective Monday, October 8,2007. In addition, ... Board,ticker symbol will change to "ECTE" and its ...
... ON, Oct. 5 /PRNewswire-FirstCall/ - Bioniche Life Sciences,Inc., a research-based, technology-driven Canadian biopharmaceutical,company (TSX:BNC), will be ... cattle vaccine,during a: ... ... ...
... 5 Sundance Catalog is proud to,support Susan G. ... end breast,cancer forever by empowering people, ensuring quality care ... of the retail sales price of,the Cherokee "Health" Tee ... a guaranteed minimum donation of $5,000.00. The Cherokee word,for ...
... Edward G. Rendell,today joined the Pennsylvania Dental Association (PDA) ... recognizing October 5, 2007,as Senior Smiles Day in Pennsylvania. ... individual,s overall,health and quality of life," Rendell said in ... adults over the age of sixty-five reside,in the commonwealth ...
... In a significant advancement in the ongoing battle against ... IC-MedTech and other institutions have completed the first ever ... Apatone exploits a new strategy to selectively lower the ... energy production and protect against chemotherapy. This non-toxic ...
... 5 Florida drivers won a major,victory today ... no-fault auto insurance law. The reformed law, which ... both chambers with,overwhelming support. The new changes in ... The Coalition particularly applauded Senator Bill Posey ...
Cached Medicine News:Health News:Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc. 2Health News:Cherokee 'Health' Tee Proceeds Benefit Breast Cancer Research 2Health News:Governor Rendell Declares Senior Smiles Day in Pennsylvania; Goal is to Improve Oral Hygiene for Senior Citizens 2Health News:Researchers complete first clinical trial of Apatone for cancer treatment 2Health News:Researchers complete first clinical trial of Apatone for cancer treatment 3Health News:Hospitals and the Coalition to Protect Florida's Drivers Applaud Lawmakers for Reviving No-Fault Insurance 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: